Global metabolomics reveals metabolic dysregulation in ischemic retinopathy-Reference-Cited by-同舟云学术

Global metabolomics reveals metabolic dysregulation in ischemic retinopathy

Published:2015-11-18 Issue:1 Volume:12 Page:
ISSN:1573-3882
Container-title:Metabolomics
language:en
Short-container-title:Metabolomics

Author:

Paris Liliana P.,Johnson Caroline H.,Aguilar Edith,Usui Yoshihiko,Cho Kevin,Hoang Lihn T.,Feitelberg Daniel,Benton H. Paul,Westenskow Peter D.,Kurihara Toshihide,Trombley Jennifer,Tsubota Kinya,Ueda Shunichiro,Wakabayashi Yoshihiro,Patti Gary J.,Ivanisevic Julijana,Siuzdak Gary,Friedlander Martin

Funder

National Eye Institute (US), NIH

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11306-015-0877-5.pdf

Reference24 articles.

1. Bringmann, A., et al. (2006). Muller cells in the healthy and diseased retina. Progress Retinal Eye Research, 25, 397–424. doi: 10.1016/j.preteyeres.2006.05.003 .

2. Cheung, N., Wong, I. Y., & Wong, T. Y. (2014). Ocular anti-VEGF therapy for diabetic retinopathy: overview of clinical efficacy and evolving applications. Diabetes Care, 37, 900–905. doi: 10.2337/dc13-1990 .

3. Das, A., Stroud, S., Mehta, A., & Rangasamy, S. (2015). New treatments for diabetic retinopathy. Diabetes, Obesity & Metabolism, 17, 219–230. doi: 10.1111/dom.12384 .